Ingevity Corp
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
NGVT$60.78-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Years Ended December 31, | |||
|---|---|---|---|
| In millions | 2024 | 2023 | 2022 |
| Cash provided by (used in) operating activities: | |||
| Net income (loss) | $(430.3) | $(5.4) | $211.6 |
| Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||
| Depreciation and amortization | 108.3 | 122.8 | 108.8 |
| Non cash operating lease costs | 19.1 | 18.6 | 16.1 |
| Deferred income taxes | (121.4) | (44.7) | (5.0) |
| Disposal/impairment of assets | 1.3 | 4.3 | 2.5 |
| Restructuring and other (income) charges, net | 186.2 | 170.2 | 13.8 |
| CTO resales | 52.7 | 22.0 | — |
| LIFO reserve | (18.7) | 72.9 | 10.0 |
| Share-based compensation | 11.9 | 10.6 | 16.1 |
| (Gain) loss on strategic investment | 11.4 | (19.3) | — |
| Pension and other postretirement benefit costs | 1.5 | 1.6 | 1.4 |
| Goodwill impairment charge | 349.1 | — | — |
| Other non-cash items | 17.0 | 36.2 | 18.4 |
| Changes in operating assets and liabilities, net of effect of acquisitions: | |||
| Accounts receivable, net | 38.2 | 42.7 | (42.1) |
| Inventories, net | 86.2 | (75.6) | (63.7) |
| Prepaid and other current assets | 7.7 | (28.6) | (0.8) |
| Planned major maintenance outage | (6.5) | (12.8) | (9.1) |
| Accounts payable | (63.4) | (14.6) | 42.7 |
| Accrued expenses | (1.0) | (7.7) | 0.8 |
| Accrued payroll and employee benefits | 8.0 | (33.5) | 5.4 |
| Income taxes | (13.8) | 6.4 | 4.9 |
| Operating leases | (21.7) | (22.5) | (18.8) |
| Restructuring and other spending | (59.3) | (44.0) | (13.8) |
| CTO resales | (46.1) | (10.6) | — |
| Changes in all other operating assets and liabilities, net | 12.2 | 16.1 | 14.2 |
| Net cash provided by (used in) operating activities | $128.6 | $205.1 | $313.4 |
| Cash provided by (used in) investing activities: | |||
| Capital expenditures | (77.6) | (109.8) | (142.5) |
| Payments for acquired businesses, net of cash acquired | — | — | (344.5) |
| Proceeds from sale of strategic investment | — | 31.5 | — |
| Net investment hedge settlement | — | — | 14.7 |
| Purchase of strategic investments | (0.3) | (2.4) | (77.4) |
| Other investing activities, net | (1.6) | 3.4 | (2.2) |
| Net cash provided by (used in) investing activities | $(79.5) | $(77.3) | $(551.9) |
Consolidated Statements of Cash Flows (continued)
| Years Ended December 31, | |||
|---|---|---|---|
| In millions | 2024 | 2023 | 2022 |
| Cash provided by (used in) financing activities: | |||
| Proceeds from revolving credit facility and other borrowings | 404.5 | 376.3 | 1,164.7 |
| Payments on revolving credit facility and other borrowings | (470.6) | (382.9) | (336.7) |
| Payments on long-term borrowings | — | — | (628.1) |
| Debt issuance costs | — | (0.4) | (3.0) |
| Debt repayment costs | — | — | (3.8) |
| Financing lease obligations, net | (1.0) | (0.7) | (0.9) |
| Tax payments related to withholdings on vested equity awards | (3.1) | (4.8) | (2.2) |
| Proceeds and withholdings from share-based compensation plans, net | — | 4.7 | 4.1 |
| Repurchases of common stock under publicly announced plan | — | (92.1) | (145.2) |
| Other financing activities, net | — | — | (0.8) |
| Net cash provided by (used in) financing activities | $(70.2) | $(99.9) | $48.1 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | (21.1) | 27.9 | (190.4) |
| Effect of exchange rate changes on cash | (4.2) | (0.3) | (6.0) |
| Change in cash, cash equivalents, and restricted cash | (25.3) | 27.6 | (196.4) |
| Cash, cash equivalents, and restricted cash at beginning of period | 111.9 | 84.3 | 280.7 |
| Cash, cash equivalents, and restricted cash at end of period (1) | $86.6 | $111.9 | $84.3 |
| _______________ | |||
| (1) Includes restricted cash of $18.6 million, $16.0 million, and $7.6 million and cash and cash equivalents of $68.0 million, $95.9 million, and $76.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Restricted cash is included within "Prepaid and other current assets" and "Restricted investment" within the consolidated balance sheets. | |||
| Supplemental cash flow information: | |||
| Cash paid for interest, net of capitalized interest | $85.4 | $82.7 | $54.8 |
| Cash paid for income taxes, net of refunds | 26.9 | 29.7 | 54.8 |
| Purchases of property, plant, and equipment in accounts payable | 2.4 | 2.8 | 4.9 |
| Leased assets obtained in exchange for new finance lease liabilities | — | 0.2 | — |
| Leased assets obtained in exchange for new operating lease liabilities | 6.0 | 29.1 | 23.7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.